SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000882104-13-000049
Filing Date
2013-11-06
Accepted
2013-11-06 16:01:38
Documents
14
Period of Report
2013-11-06
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K pdli-20131106x8xkdoc.htm 8-K 32808
2 PRESS RELEASE pdli-20131106x8xkex991.htm EX-99.1 186604
3 PRESENTATION pdli-20131106x8xkex992.htm EX-99.2 4099
4 INFORMATION SHEET pdli-20131106x8xkex993.htm EX-99.3 708025
5 pdllogo75.jpg GRAPHIC 5218
6 slide1.jpg GRAPHIC 74726
7 slide2.jpg GRAPHIC 149596
8 slide3.jpg GRAPHIC 117937
9 slide4.jpg GRAPHIC 58042
10 slide5.jpg GRAPHIC 52482
11 slide6.jpg GRAPHIC 52365
12 slide7.jpg GRAPHIC 64841
13 slide8.jpg GRAPHIC 85977
14 slide9.jpg GRAPHIC 65504
  Complete submission text file 0000882104-13-000049.txt   1935167
Mailing Address 932 SOUTHWOOD BLVD INCLINE VILLAGE NV 89451
Business Address 932 SOUTHWOOD BLVD INCLINE VILLAGE NV 89451 775-832-8500
PDL BIOPHARMA, INC. (Filer) CIK: 0000882104 (see all company filings)

IRS No.: 943023969 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-19756 | Film No.: 131196454
SIC: 2836 Biological Products, (No Diagnostic Substances)